Share: Facebook Twitter LinkedIn
Activity Provided By:

The France Foundation

Monoclonal Antibodies in the Treatment of at Risk Patients With COVID-19 to Reduce Hospitalization and Severe Disease

Access Activity

Overview / Abstract:

EXPLORE educational module with highly interactive and engaging online content, designed to allow learners to traverse non-linearly, depending on their educational needs and interests.
• Review the utility of monoclonal antibodies use for the management of at risk patients with COVID-19, including variants
• Explain how management of COVID-19 with monoclonal antibodies affects viral load
• Recognize specific IDSA and NIH guideline-recommended treatments for at risk, select appropriate monoclonal antibody therapy for patients with COVID-19, including combination therapy
• Describe the use of monoclonal antibodies in immunosuppressed patients with COVID-19
• Discuss the safety and efficacy of the available and emerging monoclonal antibodies for the management of at risk patients with COVID-19


Nov 29, 2022


Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME


MOOC (Massive Open Online Course), Online

Credits / Hours

1 AMA PRA Category 1 credit



Presenters / Authors / Faculty

Peter Chen, MD
Director, Pulmonary and Critical Care Medicine
Professor of Medicine
Professor of Biomedical Sciences
Assistant Medical Director
Women’s Guild Lung Institute
Director, Physician-scientist training track, Internal Medicine Training Program
Director, Physicians in Doctoral Research
Comprehensive Cancer Institute
Department of Medicine
Cedars-Sinai Medical Center
Los Angeles, CA

Lisa Lancaster, MD
Medical Director, Interstitial Lung Disease Program
Medical Advisor for Pulmonary Rehabilitation Program at Dayani Center
Vanderbilt University Medical Center
Nashville, TN

Activity Specialities / Related Topics

Asthma, Family Medicine, Infusion Therapy, Preventive Care, Primary Care, Pulmonary Medicine / COPD

Sponsors / Supporters / Grant Providers


Keywords / Search Terms

The France Foundation COVID, transfusion treatment, monoclonal antibodies, patient interview, high risk for COVID, kinetics of infection, host cell Free CE CME

Access Activity

CORE Higher Education Group,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps.CORE Higher Education Group,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the Terms of Service. Site Map